Gupta, V.K. 2023. Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye. Journal of Neuroscience and Neurological Disorders. 7, 2 (Nov. 2023), 134–154. DOI:https://doi.org/10.29328/journal.jnnd.1001087.